Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Historical Holders from Q1 2014 to Q4 2024

Symbol
AXDX on Nasdaq
CUSIP
00430H102
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
325K
Holdings value
$390K
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Indaba Capital Management, L.P. 9.9% $3.3M 2.75M Indaba Capital Management, L.P. Feb 4, 2025

Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 325K $390K $1.20 1
2024 Q3 325K $556K $0 $1.71 1
2024 Q2 325K $381K $0 $1.17 1
2024 Q1 325K $322K -$171K $0.99 1
2023 Q4 294K $1.15M -$24.6K $3.92 2
2023 Q3 292K $1.68M -$27.2M $5.75 2
2023 Q2 22M $17.8M -$1.72M $0.81 46
2023 Q1 24.5M $17.1M -$721K $0.70 63
2022 Q4 25.5M $18M -$2.26M $0.71 69
2022 Q3 26.4M $40.1M +$12.9M $1.52 71
2022 Q2 18.6M $18.4M -$4.68M $0.99 61
2022 Q1 20.2M $29.1M -$1.71M $1.44 90
2021 Q4 23.2M $121M +$492K $5.22 96
2021 Q3 23.5M $138M -$3.02M $5.83 103
2021 Q2 24.1M $194M -$4.06M $8.06 91
2021 Q1 24.6M $205M -$23.8M $8.32 96
2020 Q4 27.7M $210M -$8.35M $7.58 110
2020 Q3 27.2M $290M -$2.8M $10.66 109
2020 Q2 29.5M $448M +$4.63M $15.16 118
2020 Q1 29.2M $243M -$6.11M $8.33 100
2019 Q4 30.2M $511M +$12.3M $16.90 102
2019 Q3 25.8M $479M +$934K $18.57 108
2019 Q2 29.1M $665M +$51M $22.88 111
2019 Q1 27M $567M -$5.99M $21.02 108
2018 Q4 27.4M $315M +$10.1M $11.50 101
2018 Q3 26.5M $608M +$45.1M $22.95 114
2018 Q2 24.5M $546M +$80.3M $22.30 112
2018 Q1 20.9M $477M -$142K $22.85 113
2017 Q4 20.7M $543M -$30M $26.20 111
2017 Q3 22.1M $495M +$43M $22.45 113
2017 Q2 20.2M $554M +$12.8M $27.35 114
2017 Q1 20.3M $492M +$162M $24.20 94
2016 Q4 15.1M $314M +$14.3M $20.75 103
2016 Q3 14.4M $392M +$29.3M $27.26 98
2016 Q2 13.6M $196M -$4.16M $14.39 93
2016 Q1 13.7M $196M -$7.7M $14.37 89
2015 Q4 13.6M $291M +$71.2M $21.49 93
2015 Q3 10.4M $168M +$262K $16.18 87
2015 Q2 9.81M $253M +$36.2M $25.81 83
2015 Q1 8.61M $194M +$18.7M $22.50 71
2014 Q4 7.81M $150M +$11.8M $19.19 75
2014 Q3 5.34M $115M +$11.4M $21.48 70
2014 Q2 4.73M $123M -$84.7M $26.00 71
2014 Q1 8.85M $193M +$113M $21.81 55